Digital operating rooms and histotripsy therapy combine to improve outcomes More: Proximie and HistoSonics partner to transform liver tumour treatment in US Source: News
read moreIn an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad spending has crept downward as 2025 has gone on. More: AbbVie's Skyrizi, Novo's Wegovy duke it out
read moreThe FDA listed observations at plants run by Sun Pharma, Daewoo Pharmaceutical and Glenmark, citing concerns ranging from mold to quality control issues. More: FDA hands down citations to 3 drugmakers after inspections found contamination, testing concerns Source: fierce
read moreLeading up to the entry of the first Stelara biosimilars in the U.S. at start of 2025, executives at Johnson & Johnson remained steadfast in their belief that they could maintain revenue growth despite the patent expiry. Now, after setting
read moreIn a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey. The terms of the deal were not disclosed. More: Thermo Fisher bolsters
read moreGSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to patients in poorer nations for HIV treatment. More: GSK expands Medicines Patent
read more© 1994 - 2025 B.M. Pharmaceuticals